The first time I piped up about my food intolerances, my voice shook. I’d been diagnosed with a gut condition I won’t bore you with (thus explaining the gnarly way my body felt after a few bites of certain foods) and for months, I retreated to the dull safety of a mostly Paleo diet at home. That’s a major bummer for someone who writes about food for a living, so after consulting with my healthcare pros and industry pals, I ventured out for a meal with my script scrolling across the back of my eyes like a news ticker.
After the specials spiel, the server slipped into the rote text she’d likely recited tens of thousands of times, “Does anyone have any allergies, restrictions?” and for once I had a refrain. “Um,” I wobbled, “I have a few…” She raised pen to pad. “I’m sorry.” She lowered her hands and looked into my eyes. “You don’t have to apologize. It’s your body. And it’s my job to keep you safe.”
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.